[Home ] [Archive]   [ فارسی ]  
:: Volume 24, Issue 4 ( Scientific Journal of Kurdistan University of Medical Sciences 2019) ::
SJKU 2019, 24(4): 125-137 Back to browse issues page
Evaluation of the effect of montelukast on cadmium induced toxicity in human embryonic kidney cells (HEK-293)
Farnoosh Kaviani1 , Seyedeh Missagh Jalali Dr 2, Elham Hoveizi3, Javad Jamshidian4, Masoomeh Ahmadizadeh5
1- PhD of Veterinary Cinical Pathology, Department of Clinical Sciences, Faculty of Veterinary Medicine, Shahid Chamran University of Ahvaz, Ahvaz, Iran.
2- Assistant Professor of Clinical Pathology, Department of Clinical Sciences, Faculty of Veterinary Medicine, Shahid Chamran University of Ahvaz, Ahvaz, Iran. , mi.jalali@scu.ac.ir
3- Assistant Professor of Clinical Pathology, Department of Clinical Sciences, Faculty of Veterinary Medicine, Shahid Chamran University of Ahvaz, Ahvaz, Iran
4- Assistant Professor of Pharmacology, Department of Basic Sciences, Faculty of Veterinary Medicine, Shahid Chamran University of Ahvaz, Ahvaz, Iran.
5- Professor of Toxicology, Department of Toxicology, Faculty of Health, Jundishapur University of Medical Sciences, Ahvaz, Iran.
Abstract:   (183 Views)
Background and Aim: Industrialization of communities has resulted in a rise in cadmium accumulation in the plants, and also organs of human and animals. Kidney is the main target organ for cadmium accumulation and toxicity. The aim of this study was to investigate the effects of montelukast on cadmium toxicity in renal cells.
Materials and Methods: This experimental study was performed on human embryonic kidney cells of HEK-293 class. The study included six groups. Group one was our control group. Group 2:  treated with different concentrations of cadmium chloride; group 3: treated with different concentrations of montelukast; group 4: exposed to cadmium chloride IC50 for 24 hours, then treated with montelukast at therapeutic concentration for 24 and 72 hours; group 5: treated with montelukast at therapeutic concentration for 24 hours followed by cadmium chloride IC50 for 24 and 72 hours; group 6: simultaneously exposed to cadmium chloride IC50 and montelukast at therapeutic concentration for 24 and 72 hours. Cell viability and changes in the cell nuclei were determined at specific times by MTT test and DAPI staining, respectively. Finally, the data were statistically analyzed by ANOVA.
Results: Montelukast administration resulted in a significant increase in the viability of cadmium exposed kidney cells. The results of MTT test and DAPI staining showed that treatment with montelukast decreased cadmium induced cell deformation and led to significant improvement of the damaged cells (p<0.05).
Conclusion: Considering the beneficial effects of montelukast on renal cells, it can be recommended for prevention or treatment of cadmium toxicity.
Keywords: Cadmium chloride, Leukotriene Antagonists, Stem cells, Cell viability
Full-Text [PDF 967 kb]   (44 Downloads)    
Type of Study: Applicable | Subject: General
Received: 2019/06/4 | Accepted: 2019/07/28
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Kaviani F, Jalali S M, Hoveizi E, Jamshidian J, Ahmadizadeh M. Evaluation of the effect of montelukast on cadmium induced toxicity in human embryonic kidney cells (HEK-293). SJKU. 2019; 24 (4) :125-137
URL: http://sjku.muk.ac.ir/article-1-5082-en.html


Volume 24, Issue 4 ( Scientific Journal of Kurdistan University of Medical Sciences 2019) Back to browse issues page
مجله علمی دانشگاه علوم پزشکی کردستان Scientific Journal of Kurdistan University of Medical Sciences
مجله علمی دانشگاه علوم پزشکی کردستان Scientific Journal of Kurdistan University of Medical Sciences
Persian site map - English site map - Created in 0.07 seconds with 31 queries by YEKTAWEB 4006